Showing Results for
- Academic Journals (121)
Search Results
- 121
Academic Journals
- 121
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)Clinical study Use of the amphetamines Benzedrine [dl-amphetamine] and Dexedrine [dexamfetamine] may be linked to an increased risk of Parkinson's disease, according to findings that will be presented at the upcoming...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)Case report A 32-year-old woman with hidradenitis suppurativa developed acute generalised exanthematous pustulosis (AGEP) following administration of isotretinoin. The woman had a long-term history of hidradenitis...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)Case report A 69-year-old man developed a hypersensitivity reaction, including fever, nausea, rash, mild angioedema and tachycardia, while receiving clopidogrel [route not stated]. The man was initially admitted...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)Case report A 69-year-old man had a recurrence of thyroid MALT lymphoma and was treated with two cycles of R-THP-COP chemotherapy, which included rituximab, cyclophosphamide, pirarubicin, prednisolone sodium succinate,...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...
-
From:Reactions Weekly (Issue 1341)An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...